Heron Therapeutics (HRTX) PT Lowered to $13 at Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Heron Therapeutics (HRTX) PT Lowered to $20 at Cantor Fitzgerald
March 1, 2022 7:22 AM ESTCantor Fitzgerald analyst Brandon Folkes lowered the price target on Heron Therapeutics (NASDAQ: HRTX) to $20.00 (from $26.00) while maintaining a Neutral rating.
... MoreHeron Therapeutics (HRTX) PT Lowered to $16 at Needham & Company on Financial Overhang Concerns
March 1, 2022 6:31 AM ESTNeedham & Company analyst Serge Belanger lowered the price target on Heron Therapeutics (NASDAQ: HRTX) to $16.00 (from $24.00) while maintaining a Buy rating, following the company's most recent quarterly report.
The analyst quotes: "HRTX's 4Q21 disappointed with Zynrelef sales of $0.8MM (vs. $2.1MM in... More
Bitnile (NILE) Issues February 2022 Mining Update
March 1, 2022 6:31 AM ESTBitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (BitNile or the Company) today published an unaudited update on Bitcoin production and miner installation. The number of miners and production capacity metrics within this press release represent the S19j Pro Antminers at the Michigan data center. BitNiles Bitcoin mining production is currently operating at an... More
Heron Therapeutics (HRTX) PT Lowered to $40 at Evercore ISI
March 1, 2022 4:32 AM ESTEvercore ISI lowered its price target on Heron Therapeutics (NASDAQ: HRTX) to $40.00 (from $60.00) while maintaining a Outperform rating.... More
Heron Therapeutics (HRTX) Tops Q4 EPS by 4c
February 28, 2022 4:28 PM ESTHeron Therapeutics (NASDAQ: HRTX) reported Q4 EPS of ($0.54), $0.04 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $20.66 million versus the consensus estimate of $25.59 million.
For earnings history and earnings-related data on Heron Therapeutics (HRTX) click here.
... More